Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Create “Limited” Rx Import System, Ex-CMS Head Predicts

Executive Summary

The Bush Administration will initiate a "limited" pharmaceutical importation program during 2004, former Centers for Medicare & Medicaid Services Administrator Tom Scully predicted during the Medco drug trend symposium May 18 in Lake Buena Vista, Fla
Advertisement

Related Content

Pfizer Competes With Canadian Imports On Price With “Pfriends” Program
Pfizer Competes With Canadian Imports On Price With “Pfriends” Program
GSK Sales Reps Speaking Out Against Rx Importation In Grassroots Effort
GSK Sales Reps Speaking Out Against Rx Importation In Grassroots Effort
Waxman/Hatch Reforms Still Allow Multiple 30-Month Stays, PhRMA Says
Import Portents Aligning: HHS Secretary Says Law May Be Unstoppable
Import Portents Aligning: HHS Secretary Says Law May Be Unstoppable
Rx Importation May Be Price For Moving McClellan To CMS
Bush Generic Drug Reform Proposal Unlikely To End Push For Legislation
Advertisement
UsernamePublicRestriction

Register

PS044021

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel